|
|
.
See Category: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
ICD-10 (CM) Code and Descriptor
|
R89.3 |
Abnormal level of substances chiefly nonmedicinal as to source in specimens from other organs, systems and tissues
|
R893 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 11 |
| 10.14%
|
21.62%
|
18.24%
|
19.59%
|
16.89%
|
6.76%
|
1.35%
|
2.03%
|
0.68%
|
0.68%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for R89.3*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
83825
|
ASSAY OF MERCURY |
4
|
4
|
|
74183
|
MRI ABD W/O CNTR FLWD CNTR |
2
|
2
|
|
A9585
|
GADOBUTROL INJECTION |
2
|
157
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
2
|
2
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
2
|
2
|
|
85652
|
RBC SED RATE AUTOMATED |
2
|
2
|
|
86140
|
C-REACTIVE PROTEIN |
2
|
2
|
|
83993
|
ASSAY FOR CALPROTECTIN FECAL |
2
|
2
|
|
87071
|
CULTURE AEROBIC QUANT OTHER |
1
|
1
|
|
87205
|
SMEAR GRAM STAIN |
1
|
1
|
|
74181
|
MRI ABDOMEN W/O CONTRAST |
1
|
1
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1
|
1
|
|
45331
|
SIGMOIDOSCOPY AND BIOPSY |
1
|
1
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
1
|
1
|
|
83519
|
RIA NONANTIBODY |
1
|
1
|
|
83835
|
ASSAY OF METANEPHRINES |
1
|
1
|
|
84439
|
ASSAY OF FREE THYROXINE |
1
|
1
|
|
84443
|
ASSAY THYROID STIM HORMONE |
1
|
1
|
|
84481
|
FREE ASSAY (FT-3) |
1
|
1
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1
|
1
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
R89.3 related to the following DRG Codes:
947-948
|
